Integrating pharmacogenomics and cheminformatics with diverse disease phenotypes for cell type-guided drug discovery
Abstract Background Large-scale pharmacogenomic resources, such as the Connectivity Map (CMap), have greatly assisted computational drug discovery. However, despite their widespread use, CMap-based methods have thus far been agnostic to the biological activity of drugs as well as to the genomic effe...
Saved in:
Main Authors: | Arda Halu, Sarvesh Chelvanambi, Julius L. Decano, Joan T. Matamalas, Mary Whelan, Takaharu Asano, Namitra Kalicharran, Sasha A. Singh, Joseph Loscalzo, Masanori Aikawa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Genome Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13073-025-01431-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment
by: Rafaela Slaviero Pinheiro Cerdeira, et al.
Published: (2025-01-01) -
New derivatives of sulfonylhydrazone as potential antitumor agents: Design, synthesis and cheminformatics evaluation
by: Sabbah Dima A., et al.
Published: (2021-12-01) -
Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
by: Borbón A, et al.
Published: (2025-01-01) -
Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity
by: Jaeseong Oh, et al.
Published: (2018-09-01) -
Systematic analysis of the pharmacogenomics landscape towards clinical implementation of precision therapeutics in Greece
by: George P. Patrinos, et al.
Published: (2025-02-01)